Summary
Cipla is prioritizing its tirzepatide brand Yurpeak in the Indian obesity market, which has become the second-largest GLP-1 product since its launch. The company may delay launching generic semaglutide if Yurpeak's demand continues to grow, while re-evaluating international opportunities later.
Maharashtra FDA withdraws Cipla Pharma license cancellation order after Bombay HC criticism
19 Sept 2026, 8:25 pm · News
Maharashtra FDA Cancels Cipla Unit's Drug Licence for Reactin Plus Irregularities
19 Sept 2026, 8:25 pm · News
Cipla Gets U.S. FDA Approval for Generic Asthma, COPD Drug
19 Sept 2026, 8:25 pm · News
Turn this story into an image post, carousel, video, audio reel, blog, and more — all from HyperFast News.
Pick a story, apply your brand template, and publish polished graphics to Facebook, Instagram, LinkedIn, and more — without opening a design tool.
Create Image PostDescribe the story, headline, colors, and style you want.
Try Prompt to PostCombine branded news graphics with narration — from your audio library, a live recording, or AI text-to-speech — and share as engaging short-form content.
Create Audio PostUpload your footage, apply a video template with baked-in headlines, add optional audio, and schedule posts across every connected social channel.
Create Video PostCombine several news items into a single swipeable carousel post — with a shared title, unified caption, and per-slide template content for maximum engagement.
Create CarouselUpload your media, craft the perfect caption with AI assistance, preview on every platform, and schedule posts for the exact moment your audience is online.
Schedule a PostTransform breaking news into long-form, SEO-optimized blog posts with AI writing, a rich text editor, featured images, and one-click social image post creation.
Create Blog PostTurn any news article into a professional anchor video with AI-generated presenters, natural voice narration, and lip-sync animation — no studio, no crew, no wait.
Learn moreAbout the public HyperFast News news feed powered by NewsEngine.
Purpose-built AI tools and business automation workflows for publishers, stores, agencies, and brands.
Products
© 2026 HyperFast. All Rights Reserved.
An initiative of Xzect Labs Private Limited
